[ ZappRx raises $25M in Series B ]

ZappRx has raised $25 million  in Series B funding.

Founded in 2012, ZappRx is a digital health company that is modernizing and simplifying the way specialty drugs are managed. The company  solves a unique dilemma in the prescription medication industry for doctors and pharmacists who treat conditions like oncology and pulmonology by getting rid of the paperwork. Many pharmacies still use fax or phone to transfer medical prescription information from the doctor, delaying the process and making mistakes more likely. ZappRx solves that by automating the via an app which can process the information in real-time.

The new funding will help the company expand in a fast-growing.

Funding  Series B
Founded  2012
Country  USA
City  Boston, Massachusetts
Founder / CEO  Zoe Barry
Deal Size  $25M
Investors  Qiming Venture Partners
 SR One
 GV
Previous Investors  Atlas Venture
 GSK (GlaxoSmithKline)
 SR One
 Life Sciences Angel Network
 David Hamamoto
 Sean Trigony
 James Glimm
 Terry Meguid

[adyen action=”checkout_button”]